Table 5. Treatment outcome of patients with autoimmune hepatitis.
Data given as n (%) and median (IQR) as indicated
| Treatment outcome | Male (n=25) | Female (n=60) | p-value | Chi-square value |
| Biochemical and clinical response rate at six months, n (%) | 16 (64%) | 38 (63.3%) | 0.57 | 20.6 |
| Relapse, n (%) | 12/16 (75%) | 16/38 (42%) | 0.02 | 12.8 |
| Time to relapse after stopping or de-escalating the drugs (months), median (IQR) | 9.5 (4-13.5) | 8.6 (6-11.75) | 0.14 | 0.78 |
| Five-year mortality, n (%) | 4 (16%) ) | 8 (13.3%) | 0.78 | 0.03 |